Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

The VRC01 Antibody Mediated Prevention (AMP) efficacy trials conducted between 2016 and 2020 showed for the first time that passively administered broadly neutralizing antibodies (bnAbs) could prevent HIV-1 acquisition against bnAb-sensitive viruses. HIV-1 viruses isolated from AMP participants who...

Descripción completa

Detalles Bibliográficos
Autores principales: Mkhize, Nonhlanhla N., Yssel, Anna E. J., Kaldine, Haajira, van Dorsten, Rebecca T., Woodward Davis, Amanda S., Beaume, Nicolas, Matten, David, Lambson, Bronwen, Modise, Tandile, Kgagudi, Prudence, York, Talita, Westfall, Dylan H., Giorgi, Elena E., Korber, Bette, Anthony, Colin, Mapengo, Rutendo E., Bekker, Valerie, Domin, Elizabeth, Eaton, Amanda, Deng, Wenjie, DeCamp, Allan, Huang, Yunda, Gilbert, Peter B., Gwashu-Nyangiwe, Asanda, Thebus, Ruwayhida, Ndabambi, Nonkululeko, Mielke, Dieter, Mgodi, Nyaradzo, Karuna, Shelly, Edupuganti, Srilatha, Seaman, Michael S., Corey, Lawrence, Cohen, Myron S., Hural, John, McElrath, M. Juliana, Mullins, James I., Montefiori, David, Moore, Penny L., Williamson, Carolyn, Morris, Lynn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337935/
https://www.ncbi.nlm.nih.gov/pubmed/37384759
http://dx.doi.org/10.1371/journal.ppat.1011469

Ejemplares similares

Ejemplares similares